Medicine & Pharmaceuticals News
Recombinant Protein Expression: Boster Biological Technology Leads in Custom Antibody Production Services
Founded in 1993, Boster Biological Technology has become a trusted name in molecular biology, focusing on antibody and protein research. Today, it is making waves with its advanced offerings in recombinant protein expression services and custom antibody production , setting benchmarks in life sciences by delivering precision-focused solutions for research laboratories worldwide. With over three decades of industry experience and unparalleled expertise in ELISA kits and antibody development, Boster Biological Technology has developed a catalog of over 20,000 antibodies and ELISA kits. The company is a leader in the field of molecular biology and immunology and continues to enable groundbreaking discoveries in life sciences. Boasting over 20 years of protein production, Boster Biological Technology has a proven track record with a 98% expression success rate and over 3000 expressions annually. Recombinant protein expression is one of Boster Biological Technology’s core competencies. This service caters to researchers requiring high-quality recombinant proteins for cellular biology, immunology, and drug discovery studies. The company employs a range of expression systems, including bacterial, mammalian, and insect cells, ensuring that clients receive proteins tailored to meet their functional and structural requirements. The company's custom antibody services have gained recognition for delivering antibodies that meet stringent specifications. Whether antigen design or final antibody production, its custom antibody services boast a pipeline that includes peptide synthesis, antigen conjugation, immunization, and hybridoma screening, culminating in specific monoclonal or polyclonal antibodies. Boster Biological Technology’s clients benefit from end-to-end support, including epitope mapping and validation, making its services ideal for diagnostic and therapeutic applications. With over three decades of experience in the field, Boster Biological Technology is renowned as an ELISA expert . Its extensive catalog of ELISA kits supports applications across immunology, neuroscience, and oncology. The company’s kits are meticulously validated to ensure high sensitivity and accuracy, contributing to its reputation as a trusted partner for academic and pharmaceutical researchers. “Our foundations always go back to maintaining quality and having strong integrity to deliver consistent products and services. Providing reliable and high-quality products is our passion. This is our way of helping the life science community thrive, helping more researchers get the best tools to move forward,” said Steven Xia, the founder of Boster Biological Technology. For more information, visit https://www.bosterbio.com/ Committed to quality, innovation, and customer satisfaction, Boster Biological Technology stands out by integrating advanced purification methods, resulting in proteins with high activity and purity levels. By maintaining strict quality control at every stage, the company ensures consistency and reproducibility, key factors for researchers conducting sensitive experiments. The company’s recombinant protein expression services are noteworthy for their scalability, accommodating small-scale research projects to large-scale industrial demands. Additionally, the company’s proprietary antibody validation techniques ensure that each product exceeds industry standards for specificity and sensitivity. Boster Biological Technology also offers ELISA troubleshooting support, setting it apart as a company that puts its customers’ success first. Researchers facing technical challenges with ELISA experiments can rely on Boster’s expertise to achieve optimal results. Taking a bold approach to research with investments in scientific collaboration, Boster Biological Technology regularly partners with research institutions and biotechnology firms to drive innovations in antibody and protein science. This collaborative ethos strengthens its position as a go-to provider of cutting-edge research tools. With over 30 years of designing high-affinity antibodies and immunoassays, Boster Biological Technology serves clients across the globe, offering expedited shipping and technical support. Founded on a bedrock of quality and integrity, its ability to address diverse research needs in an ever-evolving scientific landscape underscores its leadership in molecular biology solutions. About the Company: Founded in 1993, Boster Biological Technology is a leading provider of high-quality custom antibody production and recombinant protein expression services. Known for its expertise in ELISA, the company delivers precision-driven solutions for molecular biology, immunology, and drug discovery. Boster offers tailored services, including protein purification, custom monoclonal and polyclonal antibody development, and ELISA kits, ensuring researchers achieve reliable and reproducible results. With a strong commitment to innovation and customer success, Boster serves global clients, partnering with academic, pharmaceutical, and biotech sectors to advance scientific discovery and development.
Sugar Land Psychological Associates Expands Telehealth Mental Health Services to 42 States, Providing Accessible Care Nationwide
Wellnee Announces a New Knee Relief Patch for Enhanced Wellness and Pain Management
MDC Associates Streamlines Clinical Data Management for Successful Clinical Trials
- November 17, 2024Medicine & Pharmaceuticals
PSRI Hospital: Leading the Way in Specialized Diabetic Foot Care in Delhi NCR
Diabetes, often called the "silent killer," is responsible for numerous severe complications, including diabetic foot issues. Statistics reveal that every two seconds, someone develops a diabetic foot problem. Among these patients, nearly half experience infections, and 20% require hospitalization. Alarming data also indicates that a diabetic patient undergoes limb amputation every twenty seconds due to lack of awareness or timely intervention. Understanding Diabetic Foot A diabetic foot refers to the feet of a person with diabetes who faces heightened risks of complications such as infections, ulcerations, and tissue damage due to neuropathy and peripheral artery disease in the lower extremities. Key Signs to Watch For The early signs of a diabetic foot include noticeable changes in skin colour and temperature, swelling in the foot or ankle, and leg pain. Other symptoms might be open sores on the feet that heal slowly, ingrown or fungus-infected toenails, corns, calluses, and dry cracks around the heel. Persistent foot odour can also be a sign of an underlying issue. Symptoms and Risks Symptoms can range from numbness, tingling, and blisters to temperature changes, skin discolouration, and drainage. Some patients may experience fever, chills, or extreme illness when infections develop. If left untreated, these symptoms can escalate, leading to complications such as gangrene, deformities, Charcot foot, or even amputation. Causes of Diabetic Foot High blood sugar over time damages the nerves and blood vessels in the feet. This nerve damage, known as diabetic neuropathy, can result in numbness, pain, tingling, or loss of sensation. Management and Treatment Options at PSRI Hospital Diagnosing a diabetic foot ulcer involves a range of procedures, including blood tests, radiography, ankle-brachial index, ultrasonography, CT scans, MRI, and angiography. At PSRI Hospital, one of the best neurosurgery hospital in Delhi , a specialized team uses state-of-the-art diagnostic methods and develops personalized treatment plans for each patient. Treatment options vary depending on the issue's severity and type, including debridement, specialized dressings, and the application of ointments. Offloading techniques, such as crutches or wheelchairs, reduce pressure on the affected area. In more severe cases, intravenous antibiotics, hospitalization, or angioplasty may be necessary, which can prevent amputation in 80-85% of diabetic foot cases. Early intervention significantly reduces the need for amputation, highlighting the importance of choosing a specialist. As one of the best hospitals in Delhi NCR , PSRI is recognized not only for excellence in diabetic foot management but also as a multispecialty hospital providing leading treatments in neurosurgery, cardiology, oncology, orthopedics, and kidney care. With a dedicated 24-hour emergency service and specialized expertise across a range of treatments, PSRI Hospital remains a trusted healthcare leader in the region.
- November 5, 2024Medicine & Pharmaceuticals
Pittsburgh Behavioral Health Care: Anxiety & Depression Counseling Expanded
The Pittsburgh community now has access to Altheda Medical Center's advanced Behavioral Health Integration (BHI) care management system. The program integrates mental health treatments with primary care services, ensuring a more holistic treatment plan. More details can be found at https://altheda.com/behavioral-health/ The BHI system uses a multi-pronged framework to help patients relieve symptoms of their mental health condition and prevent it from reoccurring, even during triggering events. The team offers personalized one-on-one counseling sessions to address specific concerns, such as anxiety, depression, stress, or grief. From there, psychiatric providers evaluate and prescribe necessary medications to support the BHI treatment plan. However, the differentiating factor in all BHI care management is its close coordination with primary care plans. This allows for more coordinated treatment and continuous monitoring of every patient’s behavioral health progress. Synergistic integration ensures that each patient receives the best possible care for their condition as they work closely with a team of experienced medical professionals. “At Altheda Medical Center, we are here to support you on your journey to improved mental and emotional well-being,” says a center spokesperson. “Our dedicated team is equipped to provide compassionate care for a variety of behavioral/mental health issues, ensuring personalized treatment plans that address your specific needs.” BHI care management is available for the following conditions: anxiety, depression, insomnia, ADD/ADHD, addiction, PTSD, OCD, adjustment disorder, bipolar disorder, schizophrenia, eating disorders, and stress management. All behavioral health appointments are available on Wednesday evenings until 7:30 pm EST. While virtual sessions are available, in-person consultations are recommended if the patient needs to receive various medical tests. Altheda Medical Center offers state-of-the-art diagnostic guiding tools to enhance patient care. Aside from mental and behavioral health, the center also offers primary care, special medical services, wellness treatments, such as APRP, and aesthetic services, including dermal fillers and laser hair removal. Interested parties can find more information by visiting https://altheda.com/behavioral-health/
- November 1, 2024Medicine & Pharmaceuticals
Saanvi Botanicals: A Woman's Journey from Hormonal Acne Struggle to Natural Solution Sparks Creation of Groundbreaking Wellness Brand
Like millions of women worldwide, the founder of Saanvi Botanicals struggled with persistent hormonal acne that seemed resistant to conventional treatments. After years of using harsh chemicals that provided little relief, she decided to take matters into her own hands – literally. Today, her company Saanvi Botanicals is transforming women's skincare and wellness through the power of natural ingredients. "I was at my breaking point with severe acne," recalls the founder. "Every chemical treatment I tried either didn't work or made things worse. That's when I realized there had to be a better, more holistic approach to treating hormonal acne – one that addressed both the external symptoms and internal imbalances." This realization led to months of research into natural ingredients and holistic healing practices. The result was Saanvi Botanicals' first product: a skin brightening and acne soap that would become the cornerstone of a comprehensive natural skincare routine. The founder's personal regimen, which includes a double facial cleanser balm, 24-karat gold oil, and alternating treatments with turmeric and vitamin C masks, has not only cleared her acne but also helped fade years of scarring. However, the most groundbreaking aspect of Saanvi Botanicals' approach was the recognition that hormonal acne requires internal healing as well as external care. This understanding led to the development of now “Best Seller” Yoni Steaming Herbs and Yoni Oil, designed to help women maintain hormonal balance and reproductive health naturally. The results speak for themselves. [Reference to before/after photos] The dramatic transformation in the founder's skin tells a story that resonates with women everywhere who struggle with hormonal acne and its emotional impact. Community Education and Engagement In 2024, Saanvi Botanicals has expanded its mission beyond product development to focus on community education and engagement. Through a series of wellness events across the Bay Area, the brand is introducing women to revolutionary natural wellness products many didn't know existed. "The response at our events has been overwhelming," shares the founder. "Women are particularly intrigued by our 24 Karat Gold Oil, Yoni wellness products and the concept of holistic hormonal balance. There's a real hunger for knowledge about natural alternatives to conventional treatments." These interactive events have become more than just product showcases – they're educational forums where women can learn about traditional healing practices, natural ingredients, and the connection between hormonal health and skin conditions. Attendees can experience products firsthand and learn how to incorporate them into their daily wellness routines. "Saanvi Botanicals was born from my own journey, but it's grown into something much bigger," the founder explains. "Every product we create is designed to help women heal naturally, addressing both the visible symptoms and the root causes of their wellness concerns." The brand's holistic approach to women's wellness has struck a chord with customers who are increasingly seeking natural alternatives to conventional treatments. Each product in the Saanvi Botanicals line is carefully formulated with pure, natural ingredients, free from harsh chemicals and artificial additives. The complete Saanvi Botanicals skincare routine includes: ● Double Facial Cleanser Balm ● Skin Brightening and Acne Soap ● 24 Karat Gold Oil ● Turmeric and Vitamin C Mask ● Yoni Steaming Herbs ● Yoni Oil For more information about Saanvi Botanicals and their natural approach to women's wellness and skincare, visit saanvibotanicals.com. About Saanvi Botanicals Saanvi Botanicals is a women's wellness and skincare brand dedicated to providing natural, holistic solutions for common skin concerns and hormonal balance. Founded on the principle that true healing comes from addressing both internal and external factors, the company offers a complete line of natural products that work in harmony with women's bodies.
- October 22, 2024Medicine & Pharmaceuticals
Coriolis Pharma Launches New U.S. Entity and Platform Services
Coriolis Pharma , a biopharma company specializing in R&D and GMP drug product development, recently announced the launch of a new U.S. entity and two novel platform services designed to accelerate and de-risk the development of antibody drug candidates. The new U.S. entity allows Coriolis to provide its clients with the convenience of a local presence while taking advantage of the company's international expertise. Following the launch, U.S. customers will have access to Coriolis' business development and client project management professionals, improving collaboration and support. In addition to the new U.S. entity, Coriolis is also introducing two new platform services. The first is the Developability Assessment Platform, which enables the selection of antibody candidates with optimal biophysical properties for successful drug product development. The service is particularly beneficial for projects with limited material availability and offers multiple pricing models to cater to small biotech startups and large pharmaceutical companies. The second is the Systemic Antibody Pre-formulation Platform. This platform generates a comprehensive data set for holistic drug product development by systematically screening a broad formulation space of excipients. It assesses essential Quality Attributes (cQA) through accelerated stress testing, with the purpose of helping clients select the best lead formulations for subsequent stability studies and pre-clinical development. These new platform services aim to mitigate risks and ensure that antibody drug candidates can be developed into commercial products in line with clients' Quality Target Product Profiles (QTPP). “Because the U.S. will remain the center of innovation for biopharmaceuticals and cell and gene therapies, we believe it is critical to provide in-market project management, business development, and logistical support to our U.S. clients,” said Silvia Steyrer-Gruber, CEO of Coriolis. “The establishment of our U.S. entity opens the next chapter in expanding the global footprint of Coriolis.” She continued: "We are committed to providing our clients with the highest quality services and supporting their drug development projects throughout the entire process." Since their launch earlier this year, Coriolis' new offerings have already provided value to dozens of pharmaceutical companies and biotech startups looking to accelerate the development of antibody drug candidates. They combine the convenience of a local presence with the advantages of international expertise, supporting Coriolis’ mission to continue paving the way as a leading partner for drug product development in the U.S. market. “Coriolis’ new science-driven developability assessment and pre-formulation screening offering signify the launch of a comprehensive program aimed at delivering advanced client-focused services,” said Coriolis CCO Johannes Clemens. “Engaging with Coriolis during the discovery and pre-clinical stages enable clients to accelerate time to market, reduce development risks, and proactively manage drug product development, ultimately increasing the valuation for licensing and M&A deals.”
- October 18, 2024Medicine & Pharmaceuticals
Interventional Pain & Physical Medicine Clinic Launches Comprehensive Headache Program for Patients with Chronic Headaches
The Interventional Pain & Physical Medicine Clinic (IPPMC) is a leading facility offering specialized care through its migraine treatment center . With a focus on providing personalized treatments for individuals experiencing chronic migraines, the clinic brings together experts. These professionals work closely to diagnose and treat various types of migraines, ensuring each patient receives care to reduce both the frequency and intensity of migraine episodes. The Comprehensive Interdisciplinary Headache Program treats patients with migraines, tension headaches, cluster headaches, and mixed headache types. This program is valuable for those who have not responded well to standard medical treatments or wish to reduce their reliance on headache medications. The interdisciplinary team of pain management specialists, including physicians, physical therapists, neurologists, and nutritionists, work together to address each patient's diverse needs. The migraine treatment center strives to empower patients to gain greater control over their headaches through this program. The program's objectives include reducing the use of headache medications, alleviating physical and emotional suffering, and ultimately increasing patients' quality of life. At IPPMC, patients can access treatment options, including behavioral and cognitive techniques that help individuals identify and modify behaviors that may trigger migraines. Biofeedback and relaxation training provide stress management tools, helping patients reduce headache frequency. Craniosacral techniques, manual therapy, and joint mobilization are also part of the clinic's hands-on therapies that address physical factors contributing to headache pain. "Our migraine treatment center is designed to give patients personalized care with a focus on comprehensive migraine management," said a medical staff of the clinic. "We aim to offer solutions that not only treat symptoms but also improve long-term quality of life for those suffering from chronic migraines." IPPMC is known for its multidisciplinary approach to pain management. The clinic brings a variety of treatment options for individuals dealing with chronic pain, including medication management, diagnostic evaluations, physical therapy, and non-surgical interventional procedures performed under fluoroscopy. IPPMC also provides rehabilitation programs designed to reduce patient anxiety and stress related to chronic pain while minimizing unnecessary treatments or surgeries.
- October 18, 2024Medicine & Pharmaceuticals
Interventional Pain and Physical Medicine Clinic (IPPMC) Announces Chronic Pain Program to Enhance Patient Care
The Interventional Pain and Physical Medicine Clinic (IPPMC) is introducing its Chronic Pain Program, an outpatient rehabilitation initiative designed to enhance the quality of life for people coping with chronic pain. The program offers a comprehensive, multidisciplinary approach to reduce pain and suffering while maximizing patient function and well-being. IPPMC's Chronic Pain Program seeks to address the physical, emotional, and psychological impacts of chronic pain, focusing on reducing reliance on opioids and promoting long-term, sustainable coping strategies. The clinic's pain management services are centered on a team-based approach that integrates physicians, nurses, physical and occupational therapists, and psychologists to deliver holistic care. A spokesperson for IPPMC shared, " Our Chronic Pain Program is about more than just managing symptoms. It's about empowering patients to regain control of their lives. Chronic pain can significantly affect one's mental and emotional health, and through this program, we aim to provide patients with the resources to manage pain in a healthier and more sustainable manner. " The two-week outpatient program is designed to help patients who have experienced chronic pain for at least six months and who are struggling with functional limitations in their daily lives. Patients will engage in strength training, aerobic exercises, cognitive-behavioral therapy, stress management, and medication management, all of which are key components of the program. These methodologies are specifically structured to address negative pain behaviors and cognitive restrictions that often accompany chronic pain, such as anxiety and depression. " Chronic pain affects not only the body but also the mind, " said the spokesperson. " By addressing both, our program offers patients a comprehensive approach to healing. Our goal is to help patients take control of their pain, improve their physical conditioning, and ultimately return to work and daily activities with improved quality of life. " In addition to the physical therapies offered, the Chronic Pain Program includes group discussion therapy, individual case management, and family group therapy. IPPMC encourages patients to involve a close family member or friend in their recovery journey, particularly during the final day of the program. Admission to the program requires patients to meet specific criteria, such as experiencing chronic pain for at least six months and demonstrating a commitment to change, including discontinuing the use of narcotic medications. The clinic also emphasizes the importance of follow-up appointments after the program's completion to ensure long-term progress.
- October 17, 2024Medicine & Pharmaceuticals
Interventional Pain & Physical Medicine Clinic Provides Complex Regional Pain Syndrome Treatment
Interventional Pain & Physical Medicine Clinic (IPPMC) offers comprehensive care for individuals suffering from Complex Regional Pain Syndrome (CRPS), a chronic condition marked by intense pain, often out of proportion to any injury sustained. CRPS can significantly affect a patient's quality of life, and the clinic is providing advanced, multidisciplinary treatment options to address this complex disorder. CRPS, also known as Reflex Sympathetic Dystrophy, affects the extremities and can worsen over time if not managed early. Patients often experience heightened sensitivity, muscle weakness, and other symptoms such as swelling, changes in skin texture, and vascular irregularities. While no cure exists for CRPS, early intervention can help control symptoms, sometimes leading to spontaneous remission. IPPMC's treatment approach focuses on pain relief and improving patients' functionality. The clinic's approach to managing CRPS involves a combination of physical therapy, occupational therapy, psychological support, and cutting-edge interventional treatments. Physical therapy is vital for restoring mobility and strength in affected limbs, which helps minimize long-term complications like muscle atrophy and reduced blood flow. Each patient's treatment plan is tailored to their unique needs and goals, ensuring personalized care throughout recovery. "Complex Regional Pain Syndrome is a challenging condition to treat, but we believe that through early intervention and a personalized approach, we can significantly improve the lives of our patients," said a representative from the clinic. "Our goal is to provide a comprehensive treatment plan that addresses not only the physical symptoms but also the emotional and psychological challenges that come with it." At IPPMC, physical therapists work closely with patients to enhance their range of motion and overall mobility. Exercise routines are tailored to the individual, focusing on increasing strength and minimizing discomfort. These exercises include aerobic and anaerobic activities, with careful monitoring to ensure safety and effectiveness. This personalized approach to physical therapy is key to helping patients regain control over their condition. Psychological support is one of the essential components of treatment, as the emotional impact of CRPS can be significant. Therapists at IPPMC conduct psychological assessments for patients requiring narcotic management or those with prolonged emotional disturbances due to their condition. They understand that treating CRPS involves addressing both the physical and emotional aspects of the disorder, making psychological support a key element in the overall treatment plan.
- October 17, 2024Medicine & Pharmaceuticals
eLabNext Boosts Sample Management with Full LabTAG Compatibility for Enhanced Identification and Tracking
Today, eLabNext , an Eppendorf Group Company offering a flexible Digital Laboratory Platform equipped with a Laboratory Inventory Management System (LIMS) and Electronic Lab Notebook (ELN), announced that its platform is now compatible with LabTAG ’s, industry-leading laboratory labels and identification products, available through GA International. The strategic partnership provides the scientific community with a complete sample management system for accurate sample tracking, efficient reagent and equipment management, optimized lab workflows, and future-proofed lab operations by combining reliable labeling with efficient data management. LabTAG’s labels are engineered for maximum durability, maintaining adhesion and legibility even under the most extreme conditions, such as long-term storage in liquid nitrogen or exposure to chemicals, thereby safeguarding sample integrity and supporting rigorous research protocols. Widely used in medical research and clinical laboratories, LabTAG labels are a perfect complement to the eLabNext platform. “We are thrilled to partner with eLabNext, a leader in delivering flexible, user-friendly LIMS solutions that cater to the diverse and ever-changing needs of modern laboratories,” said George Ambartsoumian, Founder and CEO of GA International. “Our partnership ensures that our labeling solutions integrate seamlessly with eLabNext’s LIMS platform, providing a comprehensive and efficient sample management system that enhances accuracy, streamlines lab operations, and supports cutting-edge scientific research.” “LabTAG has set the standard in cryogenic and chemical resistant labeling for research labs, biobanks, and healthcare institutions,” said Zareh Zurabyan, Head of eLabNext, Americas. “Our platform's full compatibility with LabTAG products, various printers, and sample identification solutions further strengthens our mission to offer an end-to-end laboratory sample management solution.”
- October 10, 2024Medicine & Pharmaceuticals
All-Natural Itch Relief Spray: Eczema & Psoriasis Quick-Acting Solution Launched
The newly available spray, Cleered, consists of water and a blend of trace minerals often found in rare hot springs. It is formulated to replicate the soothing benefits of a hot spring bath, helping to relieve itching and reduce skin inflammation associated with various conditions such as eczema, psoriasis, rosacea, and insect bites. The itch relief spray has also been used to reduce pain and swelling from insect bites. More information is available at https://cleered.net The company notes that most users experience relief from itching within five minutes of application. However, the time needed to fully eliminate skin eruptions and redness can range from 3 to 30 days, depending on the severity of the condition. Atopic dermatitis, or eczema, is a skin condition caused by a combination of genetic and environmental factors, leading to dry, itchy patches that can be painful and embarrassing. Given that some over-the-counter remedies may contain harsh chemicals or cause side effects, Cleer Products has introduced an all-natural alternative with its new itch-relief spray. Cleered is applied directly to the affected areas and can either be left to air dry or gently rubbed in if the skin is not tender. For optimal results, the company recommends applying the spray in the evening, allowing it to work uninterrupted overnight. “Cleered has been tested for toxicity by the world’s largest and most respected laboratory, SGS,” says a spokesperson for the company. “It is based on our secret formula called Wonder Clean, which moisturizes skin better than any product we have seen.” Cleer Products also highlights that no side effects have been reported from using Cleered alone and advises against combining it with other products or medications. If redness, eruptions, or increased itching occur after application, the company recommends that users discontinue use and consult a medical professional. A satisfied customer shares, “I have two daughters who have severe cases of eczema, and we have tried everything to get rid of it or at least stop the itching temporarily. But, nothing worked until we found Cleered through a friend. I'm amazed at how it ended my daughters' suffering, and now they don’t have to hide their skin. We are truly grateful for having found this product.” During this special campaign, the company is offering a lifetime refills deal for the first 25 purchasers. To participate, customers need to email a "before" picture of the affected area before using Cleered. Once the condition has been reduced or eliminated, they will need to send an "after" picture to the company to be registered as a lifetime beneficiary if the condition arises later after the original bottle is exhausted. The company will notify those who make the first 25 list. Interested parties can find more information about Cleered at https://cleered.net
- October 4, 2024Medicine & Pharmaceuticals
ClinicalTrials.EU platform rolled out across Europe
The patient-centric platform aims to solve one of the biggest challenges in medical and pharmaceutical research - the recruitment of suitable patients. It will do this by democratising patient access to clinical trials and arming them with the latest, most comprehensive information on current trials in seven European languages. Currently, over 15,500 clinical trials are registered in Europe in the pre-recruitment or recruitment phase. However, as many as 80 percent of them will have problems obtaining or maintaining a sufficient sample, leading to delays, increased costs or abandonment of the project. On the flipside, 86% of patients are not captured by the traditional clinical trial recruitment model [3]. ClinicalTrials.EU provides a credible and trustworthy link between researchers and patients. Research information is aggregated from multiple public and commercial sources and conveyed in an understandable, engaging and patient-friendly way. Founder, Dr. Łukasz Izbicki, previously founded Farmacja.net Group, which was taken over last year by IQVIA, a global supplier of advanced analytical and technological solutions for the pharmaceutical sector. He said, of the project: “Our mission at ClinicalTrials is simple. To connect research centers actively working on rare and serious diseases and illnesses with patients actively seeking appropriate therapies and create “Clinical Trials: Easily Understood”. “Until now there has been no single place where both parties could meet with confidence and find comprehensive information in a number of different languages. This has been a huge barrier in the development of treatments, as often, the absolute numbers of patients for rare diseases might be very small and geographically diverse and it can be challenging to locate and engage with them. As many as 80% of trials face challenges with patient recruitment.” Recruiting patients for clinical trials is ineffective and expensive: often researchers rely on existing patient databases or referrals from doctors in their networks. This can mean many potential patients missing out on suitable trials. ClinicalTrials.eu aims to democratise access by putting the power in the hands of the patient and allowing them to find the best treatment with the help of AI pre-screening. This in turn, effectively gives researchers access to patients who have self-selected and therefore more likely to be suitable for the trials. The acceleration of the recruitment process means trials can be implemented faster and the path to innovative therapies coming to market is also made quicker and easier. It also opens the way to decentralized research, allowing most or all research processes to be transferred to the patient's home. This is especially important for people who cannot, for various reasons, participate in a clinical trial conducted in another city or country. This model has only recently appeared on the European market, but represents almost 25% of the clinical trials market in the US due to the convenience of patients, significant savings for sponsors, and the facilitation of the recruitment process. The European clinical trials market market in this area was valued at over USD 6 billion in 2023 and, according to forecasts, it will reach USD 9.6 billion by 2029 with an average annual growth rate in 2024-2029 (CAGR) of 7%. In the first six months when the platform was still in beta phase, it had already attracted considerable support and traction within the industry. It is now listed among major market players in partnership with NORD - US Rare Disease Organization and is a member of the EU Cross Border Clinical Trials Initiative (EU-X-CT) a joint EU Parliament and EFPICA (business) initiative. It also co-operates with a number of Patients’ Advocacy Groups, is working with the Polish Medical Research Agency and partnering with academic sites on non commercial trials, as well as co-operating commercially with Sponsors, CROs and Sites. Dr Izbicki added: “We are excited at the amount of traction we have already seen prior to a formal rollout. And this is just the start! Currently, we aggregate data for the database from publicly available sources, we have enabled individual sponsors and research centers to post information about their projects on the platform. We have acquired the first commercial customers in this area and we are seeing huge interest in this area. “By the end of the year, we plan to start working with the 30 largest CROs (Contract Research Organizations) globally, which represent around 10 percent of the clinical trials market. Our mission is to increase access to clinical trials for patients who, for various reasons, are not treated as effectively as they could be.” Prof. Wojciech Fendler, Head of the Polish Medical Research Agency concluded: "Clinical trials are critical for developing new therapies, and the success of recruitment depends on providing both patients and researchers with a unified platform as ClinicalTrials.eu that facilitates access to information and collaboration, which until now has been scattered across various sources."
- October 4, 2024Medicine & Pharmaceuticals
Ruby Reef LLC Enhances Aquarium Disease Management with Rally PRO
Ruby Reef LLC, a leader in the aquarium disease management industry, has begun offering Rally PRO, a concentrated formula designed to treat a wide range of conditions in both freshwater and marine aquariums. This product reflects the company's continued commitment to providing high-quality and effective solutions for aquarium enthusiasts. Founded in 1998 by Dr. Sam Grillo, a veteran in the biotechnology field with over four decades of experience as a tropical fish hobbyist, Ruby Reef combines scientific rigor with practical application. Dr. Grillo's extensive background in disease management across human biomedical fields and commercial aquaculture has uniquely positioned Ruby Reef to tackle the most prevalent issues faced by aquarium owners. Rally PRO is formulated to combat external parasites, dinoflagellates, marine velvet, gill flukes, clownfish disease, and bacterial infections, including tail and fin rot. This product is engineered to be safe for all types of fish, corals, and invertebrates without disrupting the biological filtration systems within aquariums. It also addresses the prevention of secondary infections, making it a comprehensive aquarium disease treatment solution . "The offering of Rally PRO represents our dedication to advancing aquarium care," stated a spokesperson. "Our goal is to ensure that every aquarium enthusiast has access to treatments that are not only effective but also safe for their aquatic environments. Rally PRO is a testament to our commitment to quality and safety." This aquarium disease treatment can be directly added to display tanks, offering ease of use without the need for quarantine or hospital tanks. Rally PRO does not interfere with the tank's biofilter, and although it temporarily changes the water color to a yellowish-green, this coloration is harmless, does not stain, and will dissipate as the treatment biodegrades. Rally PRO is recommended for use in combination with Kick-Ich PRO for optimal results. Ruby Reef advises against using Rally PRO concurrently with other treatments, chemicals, or drugs. Please note that Rally PRO is strictly for hobby aquarium use and is not suitable for human or animal consumption, nor is it intended for use in aquaculture or the production of commodities for human or animal consumption.
ALL NEWS
- Thomas Law Group, PC: Parental Rights and Custody Arrangements Report Released
- Home Games Room Unveils Innovative Solutions to Attract and Retain Top Talent in Competitive Markets
- Christer Jansson Explores Ethics and Innovation in Debut Novel Genes of the Past
- Nick’s Dog Training Announces Guarantee to “Get Your Dog to Listen to You” for Obedience and Behavioral Dog Training Across Northeast Ohio
- Strokes of Luck Recognized as Best Compassion-Driven Nonprofit for Children in 2024
- FieldEx Unveils IoT-Driven Maintenance Solution for Zero Downtime
- Dr. Robert Corkern Grant for Healthcare Students: A Gateway to Academic Excellence and Healthcare Innovation
- myBVICharter Announces Live Monitor for Exclusive New Year Yacht Charters in the Virgin Islands
- Commercial and Metal Roof Painting Services in Wellington
- AI Technology Breaks Language Barriers to Drive Global E-Commerce Success
- Bathroom Water Damage Repair & Prevention Guide Released By The Handyman Link
- Sawyer Twain Releases Ultimate Holiday Gift Guide for its Luxury Game Room Furniture Collection
- Prepare for a New Luxury Jewelry Collection Inspired by Iconic Artists and Musicians: Introducing VERGEZ from Acclaimed Celebrity Designer Philippe Vergez
- Malavika Madhuraj Unveils Lost__Lab: A New Era in Architecture
- Custom Glass Keepsake Box for Photo Print With Laser-Engraving: Selection Update
- Federal Way SureSmile Clear Aligners for Crooked Teeth: Adult Treatment Expanded
- Gulfton Dental Implants To Replace Missing Teeth: Appointments Announced
- Custom Embossed Velvet Photo Presentation Memory Box for Photographers Announced
COMMUNICATE. COMMAND. COMMERCE.
Lead the conversation of your brand & win more customers with MarketersMEDIA Solutions.
Explore Now
Google
RSS